跳至主要内容
临床试验/KCT0002645
KCT0002645招募中未知

Short-term Effects and Safety of an acute increase of intraocular pressure after Intravitreal Bevacizumab injection on Corneal Endothelial Cells

Dankook Univeristy Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • Patients with macular edema or macular degeneration who are scheduled to undergo intravitreal bevacizumab injection.
  • Causes of macular edema: diabetic macular edema, retinal vein occlusion (center, branch), central serous choroidopathy, etc.

排除标准

  • Patients were excluded if they had any ocular disease, previous any intravitreal injection, use of topical eyedrops for lowering IOP, or any ocular surgery history except cataract surgery that had no complication like phacoemulsification and posterior chamber lens implantation (PE&PCL).

研究者

发起方
Dankook Univeristy Hospital

相似试验